Actionable news
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

FDA OKs new indication for Merck's cancer med Keytruda

The FDA approves the use of Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high (at least 50%) PD-L1 expression and no EGFR or ALK...